(1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one

C20H30O4 — CID 23252092

IUPAC(1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one
SMILESCC1(C)CCC[C@]2(C)[C@H]3CC[C@H]4C(=O)OC5O[C@@H](O)[C@]3(CC[C@@H]12)[C@H]54
InChIInChI=1S/C20H30O4/c1-18(2)8-4-9-19(3)12(18)7-10-20-13(19)6-5-11-14(20)16(23-15(11)21)24-17(20)22/h11-14,16-17,22H,4-10H2,1-3H3/t11-,12+,13-,14+,16?,17-,19+,20+/m1/s1
InChIKeyRWVHMWICVBNDMW-AJTGEAAESA-N
MW334.46 g/mol
LogP3.47
Rot. Bonds

About (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one

(1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one (PubChem CID 23252092) has the molecular formula C20H30O4 and a molecular weight of 334.46 g/mol. Its IUPAC name is (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one.

Molecular Properties

Compound Name(1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one
PubChem CID23252092
Molecular FormulaC20H30O4
Molecular Weight334.46 g/mol
Exact Mass334.21
IUPAC Name(1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one
SMILESCC1(C)CCC[C@]2(C)[C@H]3CC[C@H]4C(=O)OC5O[C@@H](O)[C@]3(CC[C@@H]12)[C@H]54
InChIInChI=1S/C20H30O4/c1-18(2)8-4-9-19(3)12(18)7-10-20-13(19)6-5-11-14(20)16(23-15(11)21)24-17(20)22/h11-14,16-17,22H,4-10H2,1-3H3/t11-,12+,13-,14+,16?,17-,19+,20+/m1/s1
InChIKeyRWVHMWICVBNDMW-AJTGEAAESA-N
XLogP3.47
TPSA55.76 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500334.46
LogP ≤ 53.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one?
The IUPAC name of (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one (CID 23252092) is (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one.
What is the SMILES notation for (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one?
The canonical SMILES for (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one is CC1(C)CCC[C@]2(C)[C@H]3CC[C@H]4C(=O)OC5O[C@@H](O)[C@]3(CC[C@@H]12)[C@H]54.
What is the InChIKey of (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one?
The InChIKey is RWVHMWICVBNDMW-AJTGEAAESA-N. The full InChI is InChI=1S/C20H30O4/c1-18(2)8-4-9-19(3)12(18)7-10-20-13(19)6-5-11-14(20)16(23-15(11)21)24-17(20)22/h11-14,16-17,22H,4-10H2,1-3H3/t11-,12+,13-,14+,16?,17-,19+,20+/m1/s1.
What are the key properties of (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one?
(1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one has a molecular weight of 334.46 g/mol, XLogP of 3.47, 0 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,4S,9S,10R,13R,18R,19R)-18-hydroxy-5,5,9-trimethyl-15,17-dioxapentacyclo[11.5.1.01,10.04,9.016,19]nonadecan-14-one is sourced from PubChem (CID 23252092), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).